𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Microglia density decreases with age in a mouse model of Huntington's disease

✍ Scribed by Li Ma; A. Jennifer Morton; Louise F.B. Nicholson


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
222 KB
Volume
43
Category
Article
ISSN
0894-1491

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Huntington's disease (HD) is characterized by selective neuronal loss and reactive gliosis. In the R6/2 transgenic HD mouse model, there is no selective cell loss, although astrocytosis has been reported. Since there have been no previous studies on microglia in this model, we have undertaken a detailed investigation of microglia in six different forebrain regions in the R6/2 mouse and their wild‐type littermates at two time points. Microglia were identified using the histochemical marker isolectin B4 and interactions of genotype, region, and age were analyzed. Results showed that there was a significant decrease in the number of microglia with age in both wild‐type and R6/2 brains, which was more pronounced in the transgenic mouse. There were also morphological changes with age observed in both genotypes. As early as 7 weeks of age, structural microglial abnormalities could be seen in R6/2 brains, including bulbous swellings and long stringy processes; comparable changes were seen at 16 weeks in wild‐type brains. At 14.5 weeks, microglia in R6/2 mouse brains were smaller in size with condensed nuclei and fragmentation of their processes. We suggest that the density and morphology of microglia change with normal aging and that this process is accelerated in R6/2 brains. Such changes in the dynamic status of microglia may lead to an impairment of their neurosupportive functions. Further studies are needed to understand better the role of microglia in aging and neurodegeneration. Β© 2003 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Increased GABAergic function in mouse mo
✍ Carlos Cepeda; Amaal J. Starling; Nanping Wu; Oanh K. Nguyen; Besim Uzgil; Takah πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 559 KB

## Abstract Huntington's disease (HD) is characterized by loss of striatal γ‐aminobutyric acid (GABA)ergic medium‐sized spiny projection neurons (MSSNs), whereas some classes of striatal interneurons are relatively spared. Striatal interneurons provide most of the inhibitory synaptic input to MSSNs

Decreased adult hippocampal neurogenesis
✍ Michael H. Donovan; Umar Yazdani; Rebekah D. Norris; Dora Games; Dwight C. Germa πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 623 KB

Abnormal subgranular zone (SGZ) neurogenesis is proposed to contribute to Alzheimer's disease (AD)-related decreases in hippocampal function. Our goal was to examine hippocampal neurogenesis in the PDAPP mouse, a model of AD with age-dependent accumulation of amyloid-␀ 42 (A␀ 42 )-containing plaques

Intracerebral transplantation of neural
✍ Chia-Ron Yang; Robert K. Yu πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 286 KB

## Abstract The present investigation examined the neuroprotective benefits for combined trehalose administration with C17.2 neural stem cell transplantation in a transgenic mouse model of Huntington's disease (HD), R6/2. C17.2 neural stem cells have the potential of differentiating into a neuronal